Skip to main content
. 2022 Aug 21;50(3):643–647. doi: 10.1007/s00068-022-02080-0

Table 1.

Patients and subgroup characteristics

Males Mean age (years) Females Mean age (years)
Overall
 ISS < 16 216 42.8 ± 18.2 89 42.1 ± 21.1
 ISS ≥ 16 93 50.3 ± 19.1 38 53.6 ± 25.4
 Overall 309 45.0 ± 18.8 127 45.5 ± 22.9
Control group
 ISS < 16 59 42.7 ± 18.2 20 38.1 ± 20.4
 ISS ≥ 16 45 43.8 ± 16.9 17 46.1 ± 24.3
 Overall 104 43.1 ± 17.6 37 41.7 ± 22.3
Interim group
 ISS < 16 29 42.3 ± 18.3 19 44.8 ± 15.5
 ISS ≥ 16 6 57.0 ± 15.3 2 40.5 ± 46.0
 Overall 35 44.8 ± 18.5 21 44.4 ± 18.0
Transition group
 ISS < 16 43 42.2 ± 19.0 12 50.8 ± 22.1
 ISS ≥ 16 16 51.4 ± 19.6 6 59.3 ± 20.5
 Overall 59 45.5 ± 19.3 18 53.7 ± 21.4
Routine use group
 ISS < 16 85 42.8 ± 18.1 38 40.1 ± 23.2
 ISS ≥ 16 26 59.4 ± 19.5 13 62.7 ± 25.1
 Overall 111 46.7 ± 19.7 51 45.8 ± 25.4